Cutaneous Mastocytosis Market - Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: C129D61AEF78EN
Market Monitor Global

Abstracts

Mastocytosis is rare condition characterized by excessive accumulation of mast cells in the body tissues. Mast cells release large amounts of histamine in blood which leads to itchy skin, skin rash and hot flushes. These cells are found in skin and the lining of stomach and lungs. Mast cells accumulated in the skin is referred to as cutaneous mastocytosis. Usually affecting children, the most common symptoms of cutaneous mastocytosis is abnormal growth on the skin such as spots or blisters which can form a rash on the body. The World Health Organization (WHO) has classified cutaneous mastocytosis into three variants namely urticaria pigmentosa, diffuse cutaneous mastocytosis and solitary cutaneous mastocytosis. Besides these, there are two other forms of cutaneous mastocytosis namely nodular mastocytosis and telangiectasia macularis eruptive perstans (TMEP) which are currently under review as they are very rare form of condition.

This report contains market size and forecasts of Cutaneous Mastocytosis in Global, including the following market information:

Global Cutaneous Mastocytosis Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cutaneous Mastocytosis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antihistamines Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cutaneous Mastocytosis include AB Science, Novartis, BioCentury and Rarediseases, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cutaneous Mastocytosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cutaneous Mastocytosis Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cutaneous Mastocytosis Market Segment Percentages, by Type, 2021 (%)

• Antihistamines
• Corticosteroids
• Proton Pump Inhibitors
• Immunomodulators
• Mast Cell Stabilizers

Global Cutaneous Mastocytosis Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cutaneous Mastocytosis Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Ambulatory Surgical Centers
• Others

Global Cutaneous Mastocytosis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cutaneous Mastocytosis Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cutaneous Mastocytosis revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cutaneous Mastocytosis revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AB Science
• Novartis
• BioCentury
• Rarediseases

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cutaneous Mastocytosis Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cutaneous Mastocytosis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CUTANEOUS MASTOCYTOSIS OVERALL MARKET SIZE

2.1 Global Cutaneous Mastocytosis Market Size: 2021 VS 2028
2.2 Global Cutaneous Mastocytosis Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cutaneous Mastocytosis Players in Global Market
3.2 Top Global Cutaneous Mastocytosis Companies Ranked by Revenue
3.3 Global Cutaneous Mastocytosis Revenue by Companies
3.4 Top 3 and Top 5 Cutaneous Mastocytosis Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cutaneous Mastocytosis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cutaneous Mastocytosis Players in Global Market
  3.6.1 List of Global Tier 1 Cutaneous Mastocytosis Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cutaneous Mastocytosis Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cutaneous Mastocytosis Market Size Markets, 2021 & 2028
  4.1.2 Antihistamines
  4.1.3 Corticosteroids
  4.1.4 Proton Pump Inhibitors
  4.1.5 Immunomodulators
  4.1.6 Mast Cell Stabilizers
4.2 By Type - Global Cutaneous Mastocytosis Revenue & Forecasts
  4.2.1 By Type - Global Cutaneous Mastocytosis Revenue, 2017-2022
  4.2.2 By Type - Global Cutaneous Mastocytosis Revenue, 2023-2028
  4.2.3 By Type - Global Cutaneous Mastocytosis Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cutaneous Mastocytosis Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Ambulatory Surgical Centers
  5.1.4 Others
5.2 By Application - Global Cutaneous Mastocytosis Revenue & Forecasts
  5.2.1 By Application - Global Cutaneous Mastocytosis Revenue, 2017-2022
  5.2.2 By Application - Global Cutaneous Mastocytosis Revenue, 2023-2028
  5.2.3 By Application - Global Cutaneous Mastocytosis Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cutaneous Mastocytosis Market Size, 2021 & 2028
6.2 By Region - Global Cutaneous Mastocytosis Revenue & Forecasts
  6.2.1 By Region - Global Cutaneous Mastocytosis Revenue, 2017-2022
  6.2.2 By Region - Global Cutaneous Mastocytosis Revenue, 2023-2028
  6.2.3 By Region - Global Cutaneous Mastocytosis Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cutaneous Mastocytosis Revenue, 2017-2028
  6.3.2 US Cutaneous Mastocytosis Market Size, 2017-2028
  6.3.3 Canada Cutaneous Mastocytosis Market Size, 2017-2028
  6.3.4 Mexico Cutaneous Mastocytosis Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cutaneous Mastocytosis Revenue, 2017-2028
  6.4.2 Germany Cutaneous Mastocytosis Market Size, 2017-2028
  6.4.3 France Cutaneous Mastocytosis Market Size, 2017-2028
  6.4.4 U.K. Cutaneous Mastocytosis Market Size, 2017-2028
  6.4.5 Italy Cutaneous Mastocytosis Market Size, 2017-2028
  6.4.6 Russia Cutaneous Mastocytosis Market Size, 2017-2028
  6.4.7 Nordic Countries Cutaneous Mastocytosis Market Size, 2017-2028
  6.4.8 Benelux Cutaneous Mastocytosis Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cutaneous Mastocytosis Revenue, 2017-2028
  6.5.2 China Cutaneous Mastocytosis Market Size, 2017-2028
  6.5.3 Japan Cutaneous Mastocytosis Market Size, 2017-2028
  6.5.4 South Korea Cutaneous Mastocytosis Market Size, 2017-2028
  6.5.5 Southeast Asia Cutaneous Mastocytosis Market Size, 2017-2028
  6.5.6 India Cutaneous Mastocytosis Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cutaneous Mastocytosis Revenue, 2017-2028
  6.6.2 Brazil Cutaneous Mastocytosis Market Size, 2017-2028
  6.6.3 Argentina Cutaneous Mastocytosis Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cutaneous Mastocytosis Revenue, 2017-2028
  6.7.2 Turkey Cutaneous Mastocytosis Market Size, 2017-2028
  6.7.3 Israel Cutaneous Mastocytosis Market Size, 2017-2028
  6.7.4 Saudi Arabia Cutaneous Mastocytosis Market Size, 2017-2028
  6.7.5 UAE Cutaneous Mastocytosis Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AB Science
  7.1.1 AB Science Corporate Summary
  7.1.2 AB Science Business Overview
  7.1.3 AB Science Cutaneous Mastocytosis Major Product Offerings
  7.1.4 AB Science Cutaneous Mastocytosis Revenue in Global Market (2017-2022)
  7.1.5 AB Science Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Cutaneous Mastocytosis Major Product Offerings
  7.2.4 Novartis Cutaneous Mastocytosis Revenue in Global Market (2017-2022)
  7.2.5 Novartis Key News
7.3 BioCentury
  7.3.1 BioCentury Corporate Summary
  7.3.2 BioCentury Business Overview
  7.3.3 BioCentury Cutaneous Mastocytosis Major Product Offerings
  7.3.4 BioCentury Cutaneous Mastocytosis Revenue in Global Market (2017-2022)
  7.3.5 BioCentury Key News
7.4 Rarediseases
  7.4.1 Rarediseases Corporate Summary
  7.4.2 Rarediseases Business Overview
  7.4.3 Rarediseases Cutaneous Mastocytosis Major Product Offerings
  7.4.4 Rarediseases Cutaneous Mastocytosis Revenue in Global Market (2017-2022)
  7.4.5 Rarediseases Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cutaneous Mastocytosis Market Opportunities & Trends in Global Market
Table 2. Cutaneous Mastocytosis Market Drivers in Global Market
Table 3. Cutaneous Mastocytosis Market Restraints in Global Market
Table 4. Key Players of Cutaneous Mastocytosis in Global Market
Table 5. Top Cutaneous Mastocytosis Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cutaneous Mastocytosis Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cutaneous Mastocytosis Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cutaneous Mastocytosis Product Type
Table 9. List of Global Tier 1 Cutaneous Mastocytosis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cutaneous Mastocytosis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cutaneous Mastocytosis Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cutaneous Mastocytosis Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cutaneous Mastocytosis Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cutaneous Mastocytosis Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cutaneous Mastocytosis Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cutaneous Mastocytosis Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cutaneous Mastocytosis Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cutaneous Mastocytosis Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cutaneous Mastocytosis Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cutaneous Mastocytosis Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cutaneous Mastocytosis Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cutaneous Mastocytosis Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cutaneous Mastocytosis Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cutaneous Mastocytosis Revenue, (US$, Mn), 2023-2028
Table 30. AB Science Corporate Summary
Table 31. AB Science Cutaneous Mastocytosis Product Offerings
Table 32. AB Science Cutaneous Mastocytosis Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Cutaneous Mastocytosis Product Offerings
Table 35. Novartis Cutaneous Mastocytosis Revenue (US$, Mn), (2017-2022)
Table 36. BioCentury Corporate Summary
Table 37. BioCentury Cutaneous Mastocytosis Product Offerings
Table 38. BioCentury Cutaneous Mastocytosis Revenue (US$, Mn), (2017-2022)
Table 39. Rarediseases Corporate Summary
Table 40. Rarediseases Cutaneous Mastocytosis Product Offerings
Table 41. Rarediseases Cutaneous Mastocytosis Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cutaneous Mastocytosis Segment by Type in 2021
Figure 2. Cutaneous Mastocytosis Segment by Application in 2021
Figure 3. Global Cutaneous Mastocytosis Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cutaneous Mastocytosis Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cutaneous Mastocytosis Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cutaneous Mastocytosis Revenue in 2021
Figure 8. By Type - Global Cutaneous Mastocytosis Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cutaneous Mastocytosis Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cutaneous Mastocytosis Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cutaneous Mastocytosis Revenue Market Share, 2017-2028
Figure 12. US Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cutaneous Mastocytosis Revenue Market Share, 2017-2028
Figure 16. Germany Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2028
Figure 17. France Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cutaneous Mastocytosis Revenue Market Share, 2017-2028
Figure 24. China Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2028
Figure 28. India Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cutaneous Mastocytosis Revenue Market Share, 2017-2028
Figure 30. Brazil Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cutaneous Mastocytosis Revenue Market Share, 2017-2028
Figure 33. Turkey Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cutaneous Mastocytosis Revenue, (US$, Mn), 2017-2028
Figure 37. AB Science Cutaneous Mastocytosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Cutaneous Mastocytosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. BioCentury Cutaneous Mastocytosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Rarediseases Cutaneous Mastocytosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)